Average Co-Inventor Count = 3.25
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Allergan, Inc. (13 from 2,285 patents)
2. Allergan Sales, Inc. (1 from 228 patents)
14 patents:
1. 9820989 - Method of treating conditions with kinase inhibitors
2. 9388176 - Method of treating conditiions with kinase inhibitors
3. 9388181 - Substituted 1,2,3,4-tetrahydropyrido[3,4-E] pyrrolo[1,2-A]pyrimidines as kinase
4. 9365575 - Kinase inhibitors
5. 9321766 - Kinase inhibitors
6. 9296747 - Piperidylpyrimidine derivatives as modulators of protein kinase inhibitors and of vascular endothelial growth factor receptor 2
7. 9255096 - Substituted 1,2,3,4-tetrahydrobenzo[C][2,7] naphthyridines and derivatives thereof as kinase inhibitors
8. 8889870 - Kinase inhibitors
9. 7915443 - Sulfoximines as kinase inhibitors
10. 7531665 - Kinase inhibitors for the treatment of disease
11. 7098236 - 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
12. 7060844 - (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
13. 6747025 - Kinase inhibitors for the treatment of disease
14. 6541504 - (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors